MedPath
TGA Approval

SIMBRINZA 1%/0.2% brinzolamide 1% and brimonidine tartrate 0.2% eye drops suspension bottle (219839)

219839

SIMBRINZA 1%/0.2% brinzolamide 1% and brimonidine tartrate 0.2% eye drops suspension bottle

Novartis Pharmaceuticals Australia Pty Ltd

November 20, 2014

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/351d0ec06b514e52ddc6e2703b50fd4f.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/d08bd1941e9992811fad8f46d00e5313.pdf

Active Ingredients

brimonidine tartrate

brinzolamide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SIMBRINZA 1%/0.2% brinzolamide 1% and brimonidine tartrate 0.2% eye drops suspension bottle (219839) - TGA 批准文号 | MedPath